OptimizeRx (OPRX) Shares Outstanding (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Shares Outstanding (Entity) data on file, last reported at $20.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 1.35% year-over-year to $20.5 million; the trailing twelve-month figure through Mar 2026 stood at $20.5 million (up 1.35% YoY), and the FY2025 full-year result was $20.5 million, up 1.52% from the prior year.
• Shares Outstanding (Entity) steadied at $20.5 million in Q1 2026, from $20.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $20.5 million in Q1 2026 to a low of $17.9 million in Q1 2022.
• A 5-year average of $19.4 million and a median of $19.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) climbed 0.69% in 2023 and increased 9.17% in 2024, its largest moves.
• Tracing OPRX's Shares Outstanding (Entity) over 5 years: stood at $18.3 million in 2022, then gained by 8.81% to $19.9 million in 2023, then climbed by 1.48% to $20.2 million in 2024, then gained by 1.52% to $20.5 million in 2025, then climbed by 0.03% to $20.5 million in 2026.
• Business Quant data shows OPRX's Shares Outstanding (Entity) at $20.5 million in Q1 2026, $20.5 million in Q4 2025, and $20.3 million in Q3 2025.